FDA approves System for the Treatment of Seriously Calcified Coronary Lesions

The FDA approved the Diamondback 360 Coronary Orbital Atherectomy System for the treatment of seriously calcified coronary lesions. The system, manufactured by Cardiovascular Systems, Inc., is the first new coronary atherectomy system to be approved in over two decades.


< Back to Listings